EUVIMEDScopri EUVIMED
Open access

Exosomal lncRNA PVT1 promotes fibroblast activation and colon cancer progression via miR ‐23b‐5p signaling

Liuping You, Zhiqiang Liu, Boyu Zhang, Junhu Li, Yuenan Huang iD

The Journal of Pathology · 2026

DOI: 10.1002/path.70098 ↗

At a glance

Journal article in The Journal of Pathology, 2026. Written by Liuping You and 4 co-authors. Institution: Department of General Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, PR China. Major MEDLINE topics: RNA, Long Noncoding, Colonic Neoplasms, MicroRNAs, Exosomes. 35 references. The full text is freely available in PubMed Central. Funded by: The Technology Transfer and Development Project of Harbin Medical University.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Colon cancer progression is closely associated with the tumor microenvironment, where cancer‐associated fibroblasts (CAFs) play a pivotal role. Exosomal long non‐coding RNAs (lncRNAs) are known to modulate the tumor stroma, but the role of lncRNA PVT1 (plasmacytoma variant translocation 1) in exosome‐mediated fibroblast activation in colon cancer remains poorly understood. This study demonstrated significantly elevated PVT1 levels in colon cancer tissues. Mechanistically, hypoxia/reoxygenation (H/R) induced the recruitment of HIF‐1α to the PVT1 promoter, directly activating its transcription and subsequent exosomal loading. Exosomes derived from H/R‐treated colon cancer cells promoted fibroblast activation into a CAF phenotype. PVT1 was found to sponge miR‐23b‐5p, thereby upregulating a network of target genes. Importantly, silencing of MAPK13 , a key downstream target, significantly abrogated the PVT1 ‐mediated fibroblast‐to‐CAF transformation. In vivo experiments confirmed that exosomal PVT1 enhanced CAF infiltration and tumor growth, whereas these effects were reversed by either restoring miR‐23b‐5p expression or knocking out PVT1 . These findings uncover a novel mechanism whereby H/R‐induced exosomal PVT1 promotes fibroblast activation and CAF transformation via the miR‐23b‐5p signaling axis, providing potential diagnostic biomarkers and therapeutic targets for modulating the tumor stroma in colon cancer. © 2026 The Pathological Society of Great Britain and Ireland.

Subjects

MeSH terms (MEDLINE)

RNA, Long NoncodingColonic NeoplasmsMicroRNAsExosomesCancer-Associated FibroblastsHumansAnimalsSignal TransductionGene Expression Regulation, NeoplasticTumor MicroenvironmentDisease ProgressionMice, NudeCell Proliferation

Author keywords

cancer‐associated fibroblasts (CAFs)colon cancerexosomesfibroblast activationlncRNA PVT1miR‐23b‐5ptumor microenvironment

Substances

RNA, Long NoncodingMicroRNAsPVT1 long-non-coding RNA, humanMIRN23b microRNA, human

Authors and institutions

  • Department of General Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, PR China.

ORCID profiles: Yuenan Huang

Funding

  • The Technology Transfer and Development Project of Harbin Medical University

Cite

APA

You, L., Liu, Z., Zhang, B., Li, J., & Huang, Y. (2026). Exosomal lncRNA PVT1 promotes fibroblast activation and colon cancer progression via miR ‐23b‐5p signaling. The Journal of Pathology. https://doi.org/10.1002/path.70098

Vancouver

You L, Liu Z, Zhang B, Li J, Huang Y. Exosomal lncRNA PVT1 promotes fibroblast activation and colon cancer progression via miR ‐23b‐5p signaling. The Journal of Pathology. 2026. doi:10.1002/path.70098

BibTeX
@article{You2026,
  author = {You, Liuping and Liu, Zhiqiang and Zhang, Boyu and Li, Junhu and Huang, Yuenan},
  title = {Exosomal lncRNA PVT1 promotes fibroblast activation and colon cancer progression via miR ‐23b‐5p signaling},
  journal = {The Journal of Pathology},
  year = {2026},
  doi = {10.1002/path.70098}
}
Start for free →